Dysregulation Of Innate Immunity In HCV Genotype 1 IL28B Unfavorable Genotype Patients: Impaired Viral Kinetics And Therapeutic Response

MLA

Michael A. Polis, et al. Dysregulation Of Innate Immunity In HCV Genotype 1 IL28B Unfavorable Genotype Patients: Impaired Viral Kinetics And Therapeutic Response. July 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c6772ddc5fb9010b315279525950e91a&authtype=sso&custid=ns315887.

APA

Michael A. Polis, Joerg F. Schlaak, Antonios Katsounas, Susanna Naggie, Eva Herrmann, Alexander J. Thompson, Shyam Kottilil, Martin Trippler, Anu Osinusi, Richard A. Lempicki, Bhavana Shivakumar, John G. McHutchison, Keyur Patel, Andrew J. Muir, Henry Masur, & Paul J. Clark. (2012). Dysregulation Of Innate Immunity In HCV Genotype 1 IL28B Unfavorable Genotype Patients: Impaired Viral Kinetics And Therapeutic Response.

Chicago

Michael A. Polis, Joerg F. Schlaak, Antonios Katsounas, Susanna Naggie, Eva Herrmann, Alexander J. Thompson, Shyam Kottilil, et al. 2012. “Dysregulation Of Innate Immunity In HCV Genotype 1 IL28B Unfavorable Genotype Patients: Impaired Viral Kinetics And Therapeutic Response,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c6772ddc5fb9010b315279525950e91a&authtype=sso&custid=ns315887.